Spiroergometry in Cardiology - Clinical Applications;Spiroergometrie in der Kardiologie - Klinische Anwendungsmöglichkeiten

Journal fur Kardiologie

Volumn 10, Issue 10, 2003, Pages 440-446

  Wonisch, Manfred ^a   Kraxner, W ^a   Hodl R ^a   Watzinger, N ^a   Maier, R ^a   Hofmann, P ^b   Pokan, R ^b   Scherr, D ^a   Klein, W ^a   Fruhwald, F M ^a  

^a UNIVERSITY HOSPITAL GRAZ   (Austria)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTERIAL PRESSURE; CONGENITAL HEART DISEASE; CONGESTIVE HEART FAILURE; DYSPNEA; ELECTROCARDIOGRAM; EXERCISE TEST; FITNESS; HEART REHABILITATION; HEART TRANSPLANTATION; HUMAN; LUNG VENTILATION; MORTALITY; OXYGEN CONSUMPTION; REVIEW; RISK FACTOR; SINUS NODE; SPIROMETRY; VALVULAR HEART DISEASE;

EID: 0142184726     PISSN: 10240098     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (91)

1. Gibbons RJ, Balady GJ, Beasley JW, Bricker JT, Duvernoy WF, Froelicher VF, Mark DB, Marwick TH, McCallister BD, Thompson PD, Winters WL, Yanowitz FG. ACC/AHA Guidelines for Exercise Testing: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing). J Am Coll Cardiol 1997; 30: 260-315.
2. ACSM. American College of Sports Medicine. ACSM's Guidelines for Exercise Testing and Prescription (6th ed). Lippincott Williams & Wilkins, Philadelphia, PA, 2000, 165-99.
3. Fleg JL, Pina IL, Balady GJ, Chaitman BR, Fletcher B, Lavie C, Limacher MC, Stein RA, Williams M, Bazzarre T. Assessment of functional capacity in clinical and research applications - an advisory from the committee on exercise, rehabilitation, and prevention, council on clinical cardiology, American Heart Association. Circulation 2000; 102: 1591-7.
4. Fletcher GF, Balady G, Amsterdam EA, Chaitman B, Eckel R, Fleg J, Froelicher VF, Leon AS, Pina IL, Rodney R, Simons-Morton DG, Williams MA, Bazzarre T. Exercise standards for testing and training - a statement for healthcare professionals from the American Heart Association. Circulation 2001; 104: 1694-740.
5. American Heart Association. Exercise testing and training of apparently healthy individuals: a handbook for physicians, 1972, 15. In: Thompson PD. Exercise & Sports Cardiology. McGraw-Hill, New York, 2001; 10.
6. Ashley EA, Myers J, Froelicher V. Exercise testing in clinical medicine. Lancet 2000; 356: 1592-7.
7. Morris CK, Ueshima K, Kawaguchi T, Hideg A, Froelicher VF. The prognostic value of exercise capacity: a review of the literature. Am Heart J 1991; 122: 1423-31.
8. Blair SN, Cheng Y, Holder JS. Is physical activity or physical fitness more important in defining health benefits? Med Sci Sports Exerc 2001; 33: S379-S399.
9. Snader CE, Marwick TH, Pakhow FJ, Harvey SA, Thomas JD, Lauer MS. Importance of estimated functional capacity as a predictor of allcause mortality among patients referred for exercise thallium single-photon emission computed tomography: report of 3,400 patients from a single center. J Am Coll Cardiol 1997; 30: 641-8.
10. Myers J, Prakash M, Froelicher V, Do D, Partington S, Atwood JE. Exercise capacity and mortality among men referred for exercise testing. N Engl J Med 2002; 346: 793-801.
11. Laukkanen JA, Lakka TA, Rauramaa R, Kuhanen R, Venäläinen V, Salonen R, Salonen JT. Cardiovascular fitness as a predictor of mortality in men. Arch Int Med 2001; 161: 825-31.
12. Dorn J, Naughton J, Imamura D, Trevisan M. Results of a multicenter randomized clinical trial of exercise and long-term survival in myocardial infarction patients - the national exercise and heart disease project (NEHDP). Circulation 1999; 100: 1764-9.
13. Goraya TY, Jacobsen SJ, Pellikka PA, Miller TD, Khan A, Weston SA, Gersh BJ, Roger VL. Prognostic value of treadmill exercise testing in elderly persons. Ann Intern Med 2000; 132: 862-70.
14. Williams PT Physical fitness and activity as separate heart disease risk factors: a meta-analysis. Med Sci Sports Exerc 2001; 33: 754-61.
15. rd, Barlow CE, Paffenbarger RS Jr, Gibbons LW, Macera CA. Changes in physical fitness and all-cause mortality: a prospective study of healthy and unhealthy men. JAMA 1995; 273: 1093-8
16. Oja P. Dose response between total volume of physical activity and health and fitness. Med Sci Sports Exerc 2001; 33: S428-S437.
17. Martinson BC, O'Connor PJ, Pronk NP. Physical inactivity and short-term all-cause mortality in adults with chronic disease. Arch Intern Med 2001; 161: 1173-80.
18. Reuter M, Waßermann K. Überprüfung der Validität von Parametern zur spiroergometrischen Differenzierung einer zirkulatorisch von einer ventilatorisch bedingten Leistungslimitierung. Pneumologie 1997; 51: 353-8.
19. Palage P, Carlone S, Forte S, Galassetti P, Serra P. Cardiopulmonary exercise testing in the evaluation of patients with ventilatory vs circulatory causes of reduced exercise tolerance. Chest 1994; 105: 1122-6.
20. Martinez FJ, Stanepoulos I, Acero R, Becker F, Pickering R, Beamis JF. Graded comprehensive cardiopulmonary exercise testing in the evaluation of dyspnea unexplained by routine evaluation. Chest 1994; 105: 168-74
21. Tavazzi L, Gianuzzi P, Dubach P, Opasich C, Myers J, Perk J, Meyer K, Drexler H. Working Group on Cardiac Rehabilitation & Exercise Physiology and Working Group on Heart Failure of the European Society of Cardiology: Recommendations for exercise testing in chronic heart failure patients. Eur Heart J 2001; 22: 37-45
22. McNeer JF, Margolis JR, Lee KI, Kisslo JA, Peter RH, Kong Y, Behar VS, Wallace AG, McCants CB, Rosati RA. The role of the exercise test in the evaluation of patients for ischemic heart disease. Circulation 1978; 57: 64-70.
23. Chaitman BR, McMahon RP, Terrin M, Younis LT, Shaw LJ, Weiner DA, Frederick MMJ, Knatterud GL, Sopko G, Braunwald E. Impact of treatment strategy on predischarge exercise test in the Thrombolysis in Myocardial Infarction (TIMI) II Trial. Am J Cardiol 1993; 71: 131-8.
24. Villella A, Maggioni AP, Villella M, Giordano A, Turazza FM, Santoro E, Franzosi MG. Prognostic significance of maximal exercise testing after myocardial infarction treated with thrombolytic agents: the GISSI-2 data base: Gruppo Italiano per lo Studio della Sopravivenza Nell'Infarto. Lancet 1995; 346: 523-9.
25. Nyman I, Larsson H, Areskog M, Wallentin L. The predictive value of silent ischemia at an exercise test before discharge after an episode of unstable coronary artery disease: RISC Study Group. Am Heart J 1992; 123: 324-31.
26. Winter UJ, Gitt AK, Blaum M, Fritsch J, Berge PG, Pothoff G, Hilger HH. Kardiopulmonale Leistungsfähigkeit bei Patienten mit koronarer Herzkrankheit. Z Kardiol 1994; 83 (Suppl 3): 73-82.
27. Reilly DF, McNeely MJ, Doerner D, Greenberg DL, Staiger TO, Geist MJ, Vedovatti PA, Fihn SD. Self-reported exercise tolerance and the risk of serious perioperative complications. Arch Intern Med 1999; 116: 2185-92.
28. Older P, Hall A, Hader R. Cardiopulmonary exercise testing as a screening test for perioperative management of major surgery in the elderly. Chest 1999; 116: 355-62.
29. Eagle KA, Berger PB, Calcins H, Chaitman BR, Ewy GA, Fleischmann KI, Fleisher LA, Froehlich JB, Gusberg RJ, Leppo JA, Ryan T, Schlant RC, Winters WL Jr. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Circulation 2002; 105: 1257-67
30. O'Connor GT, Buring JE, Yusuf S, Goldhaber SZ, Olmstead EM, Paffenbarger RS Jr, Hennekens CH. An overview of randomised trials of rehabilitation with exercise after myocardial infarction. Circulation 1989; 80: 234-44.
31. Pokan R, Hofmann P, Preidler K, Leitner H, Dusleag J, Eber B, Schwaberger G, Füger GF, Klein W. Correlation between inflection of heart rate/work performance curve and myocardial function in exhausting cycle ergometer exercise. Eur J Appl Physiol 1993; 67: 385-8.
32. Pokan R, Hofmann P, Von Duvillard SP, Beaufort F, Schumacher M, Fruhwald FM, Zweiker R, Eber B, Gasser R, Brandt D, Smekal G, Klein W, Schmid P. Left ventricular function in response to the transition from aerobic to anaerobic metabolism. Med Sci Sports Exerc 1997; 29: 1040-7.
33. Pokan R, Hofmann P, Von Duvillard SP, Beaufort F, Smekal G, Gasser R, Klein W, Bachl N, Schmid P. The heart rate performance curve and left ventricular function during exercise in patients after myocardial infarction. Med Sci Sports Exerc 1998; 30: 1475-80.
34. Hofmann P, Pokan R, Preidler K, Leitner H, Szolar D, Eber B, Schwaberger G. Relationship between heart rate threshold, lactate turn point and myocardial function. Int J Sports Med 1994; 15: 232-7
35. Wonisch M. Einfluss von kardioselektiver Beta-Rezeptoren-Blockade auf die körperliche Leistungsfähigkeit und das subjektive Empfinden unter besonderer Berücksichtigung der anaeroben Schwelle bei jungen gesunden Männern. Dissertation an der Karl-Franzens-Universität Graz, 2002.
36. Wonisch M, Hofmann P, Schwaberger G, Von Duvillard SP, Fruhwald FM, Hödl R, Stoschitzky K, Pokan R, Klein W. Effect of bisoprolol versus placebo on different concepts of anaerobic threshold in healthy men. Med Sci Sports Exerc 2001; 33: S27.
37. nd ed. Williams & Wilkins, Philadelphia, 1994.
38. Wonisch M, Hofmann P, Fruhwald FM, Hödl R, Schwaberger G, Pokan R, von Duvillard SP, Klein W. Effect of β1-selective adrenergic blockade on maximal blood lactate steady state in healthy men. Eur J Appl Physiol 2002; 87: 66-71.
39. Remme WJ, Swedberg K. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 2001; 22: 1527-60.
40. Itoh H, Taniguchi K, Koike A, Doi M. Evaluation of severity of heart failure using ventilatory gas analysis. Circulation 1990; 81 (Suppl II): 1131-1137.
41. Franciosa JA, Park M, Leviane TB. Lack of correlation between exercise capacity and indexes of resting left ventricular performance in heart failure. Am J Cardiol 1981; 47: 33-9.
42. Cohen-Solal A, Chabernaud JM, Gourgon R. Comparison of oxygen uptake during bicycle exercise in patients with chronic heart failure and in normal subjects. J Am Coll Cardiol 1990; 16: 80-5.
43. Cohen-Solal A, Zannad F, Kayanakis JG, Gueret P, Aupetit JF, Kolsy H. Multicentre study of the determination of peak oxygen uptake and ventilatory threshold during bicycle exercise in chronic heart failure. Comparison of graphical methods, interobserver variability and influence of exercise protocol. The VO2 French Study Group. Eur Heart J 1991; 12: 1055-63.
44. McElroy PA, Janicki JS, Weber T. Cardiopulmonary exercise testing in congestive heart failure. Am J Cardiol 1998; 62: 35A-40A.
45. Weber KT, Janicki JS, McElroy TP. Determination of aerobic capacity and the severity of chronic cardiac and circulation failure. Circulation 1987; 76 (Suppl VI): VI40-VI45.
46. Rajfer SI, Nemanich JW, Shurman AL, Rossen JD. Metabolic responses to exercise in patients with heart failure. Circulation 1987 (Suppl VI): VI46-VI53.
47. Sullivan MJ, Cobb FR. The anaerobic threshold in chronic heart failure, Circulation 1990; 81 (Suppl II): II47-II58.
48. Mancini DM, Eisen H, Kussmaul W, Mull R, Edmunds LH, Wilson JR. Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation 1991; 83: 778-86.
49. Myers J, Gullestad L, Vagelos R, Do D, Bellin D, Ross H, Fowler MB. Clinical, hemodynamic, and cardiopulmonary exercise test determinants of survival in patients referred for evaluation of heart failure. Ann Intern Med 1998; 129: 286-93.
50. Huelsman M, Stefenelli T, Berger R, Pacher R. Prognostic impact of workload in patients with congestive heart failure. Am Heart J 2002; 143: 308-12.
51. Pardaens K, Cleemput JV, Vanhaecke J, Fagard RH. Peak oxygen uptake better predicts outcome than submaximal respiratory data in heart transplant candidates. Circulation 2000; 101: 1152-7.
52. th Bethesda conference: Cardiac transplantation. Task Force 3: Recipient guidelines/prioritization. J Am Coll Cardiol 1993; 22: 21-31
53. Chua TP, Ponikowski P, Harrington D, Anker SD, Webb-Peploe K, Clark AL, Poole-Wilson PA, Coats AJ. Clinical correlates and prognostic significance of the ventilatory response to exercise in chronic heart failure. J Am Coll Cardiol 1997; 79: 1645-50.
54. Johnson RL. Gas exchange efficiency in chronic congestive heart failure. Circulation 2000; 101: 2774-6.
55. Kleber FX, Vietzke G, Wernecke KD, Bauer U, Opitz C, Wensel R, Sperfeld A, Glaser S. Impairment of ventilatory efficiency in heart failure: prognostic impact. Circulation 2000; 101: 2803-9.
56. Corrá U, Mezzani A, Bosimini E, Scapellato F, Imparato A, Gianuzzi P. Ventilatory response to exercise improves risk stratification in patients with chronic heart failure and intermediate functional capacity. Am Heart J 2002; 143: 418-26.
57. Baniaminovitz A, Mancini D. The role of exercise-based prognosticating algorithms in the selection of patients for heart transplantation. Curr Opin Cardiol 1999; 14: 114-20.
58. Aaronson KD, Schwartz JS, Chen T, Mancini D. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation 1997; 95: 2660-7.
59. Saxon L, Stevenson W, Middlekauf, Fonarow G, Woo M, Mooser D, Stevenson L. Predicting death from progressive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 1993; 72: 62-5.
60. Cohn JN, Rector TS. Prognosis of congestive heart failure and predictors of mortality. Am J Cardiol 1988; 62: 25A-30A.
61. Costanzo M, Augustine S, Bourge R, Bristow M, O'Connell J, Driscoll D, Rose E. Selection and treatment of candidates for heart transplantation. Circulation 1995; 92: 3593-612.
62. Hunt SA, Baker DW, Chin MH, Cinquegrani MP, Feldman AM, Francis GS, Ganiats TG, Goldstein S, Gregoratos G, Jessup ML, Noble RJ, Packer M, Silver MA, Stevenson LW. ACC/ AHA guidelines for the evaluation and management of chronic heart failure in the adult: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure). Circulation 2001; 104: 2996-3007.
63. Miller LW, Kubo SH, Young JB, Stevenson LW, Loh E, Costanzo MR. Report of the consensus conference on candidate selection for heart transplantation 1993. J Heart Lung Transplant 1995; 14: 562-71.
64. Aaronson KD, Chen T, Mancini DM. Demonstration of the continuous nature of peak VO2 for prediction survival in ambulatory patients evaluated for transplant J Heart Lung Transplant 1996; 15: S66
65. Griffin BP, Shah PK, Ferguson J, Rubin SA Incremental prognostic value of exercise hemodynamic variables in chronic congestive heart failure secondary to coronary artery disease or to dilated cardiomyopathy. Am J Cardiol 1991; 67: 848-53.
66. Szlachcic J, Massie B, Kramer B, Topic N, Tubau J. Correlates and prognostic implication of exercise capacity in chronic congestive heart failure. Am J Cardiol 1985; 55: 1037-42.
67. Likoff MJ, Chandler SL, Kay HR. Clinical determinants of mortality in chronic congestive heart failure secondary to idiopathic dilated or to ischemic cardiomyopathy. Am J Cardiol 1987; 59: 634-8.
68. Pina IL. Optimal candidates for heart transplantation: Is 14 the magic number? J Am Coll Cardiol 1995; 26: 436-7.
69. Opasich C, Pinna GD, Bobbio M, Sisti M, Demichelis B, Febo O, Forni G, Riccardi R, Riccardi G, Capomolla S, Cobelli F, Tavazzi L. Peak exercise oxygen consumption in chronic heart failure: toward efficient use in the individual patient. J Am Coll Cardiol 1998; 31: 766-75.
70. Myers J, Gullestad L, Vagelos R, Do D, Bellin D, Ross H, Fowler MB. Cardiopulmonary exercise testing and prognosis in severe heart failure: 14 ml/kg/min revisited. Am Heart J 2000; 139: 78-84.
71. Cohn JN, Johnson GR, Shabetai R, Loeb H, Tristani F, Rector T, Smith R, Fletcher R. Ejection fraction, peak exercise oxygen consumption, cardiothoracic ratio, ventricular arrhythmias, and plasma norepinephrine as determinants of prognosis in heart failure. Circulation 1993; 87 (Suppl VI): VI5-VI16.
72. Stelken AM, Younis LT, Jennison SH, Miller DD, Miller LW, Shaw LJ, Kargl D, Chaitman BR. Prognostic value of cardiopulmonary exercise testing using percent achieved of predicted peak oxygen uptake for patients with ischemic and dilated cardiomyopathy. J Am Coll Cardiol 1996; 27: 345-52.
73. Metra M, Dei Cas L, Panina G, Visiolo D. Exercise hyperventilation in chronic congestive heart failure and its relation to functional capacity and hemodynamics. Am J Cardiol 1992; 70: 622-8.
74. Francis DP, Shamim W, Davies LC, Piepoli MF, Ponikowski P, Anker SD, Coats AJS. Cardiopulmonary exercise testing for prognosis in chronic heart failure: continuous and independent prognostic value from VE/VCO2 slope and peak VO2. Eur Heart J 2000; 21: 154-61.
75. Rohrer A, Pokan R, Hofmann P, Quittan M, Von Duvillard SP, Smekal G, Bachl N, Pacher R. Determination of training intensities in patients with transplanted denervated hearts. Med Sci Sports Exerc 2001; 33: S64.
76. Marzo KP, Wilson JR, Mancini DM. Effects of cardiac transplantation on ventilatory response to exercise. Am J Cardiol 1992; 69: 547-53.
77. Brubaker PH, Berry MJ, Brozena SC, Morley DL, Walter JD, Paolone AM, Bove AA. Relationship of lactate and ventilatory thresholds in cardiac transplant patients. Med Sci Sports Exerc 1993; 25: 191-6.
78. Keteyian S, Shepard R, Ehrman J, Fedel F, Glick C, Rhoads K, Levine TB. Cardiovascular responses of heart transplant patients to exercise training. J Appl Physiol 1991; 70: 2627-31.
79. Bonow RO, Carabello B, De Leon AC Jr, Edmunds LH Jr, Fedderly BJ, Freed MD, Gaasch WH, McKay CR, Nishimura RA, O'Gara PT, O'Rourke RA, Rahimtoola SH. ACC/AHA guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Valvular Heart Disease). J Am Coll Cardiol 1998; 32: 1486-588.
80. Samet P, Bernstein W, Levine S. Significance of the atrial contribution to ventricular filling. Am J Cardiol 1965; 15: 195-202.
81. Atwood JE, Myers J, Sullivan M, Forbes S, Friis R, Pewen W, Callaham P, Hall P, Froelicher V. Maximal exercise testing and gas exchange in patients with chronic atrial fibrillation. J Am Coll Cardiol 1988; 11: 508-13.
82. Ueshima K, Myers J, Morris CK, Atwood JE, Kawaguchi T, Froelicher VF. The effect of cardioversion on exercise capacity in patients with atrial fibrillation. Am Heart J 1993; 126: 1021-4.
83. Atwood JE, Myers J, Sullivan M, Forbes S, Sandhu S, Callaham P, Froelicher VF. The effect of cardioversion on maximal exercise capacity in patients with chronic atrial fibrillation. Am Heart J 1989; 118: 913-8.
84. Lipkin DP, Frenneaux M, Stewart R, Joshi J, Lowe T, McKenna WJ. Delayed improvement in exercise capacity after cardioversion of atrial fibrillation to sinus rhythm. Br Heart J 1988; 59: 572-7.
85. Lundstrom T, Karlsson O. Improved ventilatory response to exercise after cardioversion of chronic atrial fibrillation to sinus rhythm. Chest 1992; 102: 1017-22.
86. Ueshima K, Myers J, Ribisl PM, Atwood JE, Morris CK, Kawaguchi T, Liu J, Froelicher VF. Hemodynamic determinants of exercise capacity in chronic atrial fibrillation. Am Heart J 1993; 125: 1301-5.
87. Sun X-G, Hansen JE, Qudiz RJ, Wasserman K. Gas exchange detection of exercise-induced right-to-left shunt in patients with primary pulmonary hypertension. Circulation 2002; 105: 54-60.
88. Sharma S, Elliott PM, Whyte G, Mahon N, Virdee MS, Bist B, McKenna WJ. Utility of metabolic exercise testing in distinguishing hypertrophic cardiomyopathy from physiologic left ventricular hypertrophy in athletes. J Am Coll Cardiol 2000; 36: 864-70.
89. Ijiri H, Komori S, Kohno I, Sano S, Yin D, Takusagawa M, Iida T, Yamamoto K, Osada M, Swanobori T, Ishihara T, Umetani K, Tamuri K. Improvement of exercise tolerance by single lead VDD pacemaker: evaluation using cardiopulmonary exercise test. PACE 2000; 23: 1336-42.
90. Kristensson BE, Ammann K, Ryden L. The haemodynamic importance of atrioventricular synchrony and rate increase at rest and during exercise. Eur Heart J 1985; 6: 773-8.
91. Berge PG, Winter UJ, Ehmanns S, Hilger HH. Cardiopulmonary exercise capacity in WI stimulatian in patients with high grade AV block. Z Kard 1994; 83 (Suppl 3): 141-4.